These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33883369)

  • 21. Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis.
    Thakur SB; Horvat JV; Hancu I; Sutton OM; Bernard-Davila B; Weber M; Oh JH; Marino MA; Avendano D; Leithner D; Brennan S; Giri D; Manderski E; Morris EA; Pinker K
    J Magn Reson Imaging; 2019 Jul; 50(1):239-249. PubMed ID: 30605266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proton MRS in a case of intracerebellar epidermoid].
    Isobe T; Matsumura A; Anno I; Yoshizawa T; Itai Y; Nose T
    No To Shinkei; 2002 Feb; 54(2):163-6. PubMed ID: 11889764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study.
    Sah RG; Sharma U; Parshad R; Seenu V; Mathur SR; Jagannathan NR
    Magn Reson Med; 2012 Oct; 68(4):1039-47. PubMed ID: 22213087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new method to reduce false positive results in breast MRI by evaluation of multiple spectral regions in proton MR-spectroscopy.
    Clauser P; Marcon M; Dietzel M; Baltzer PAT
    Eur J Radiol; 2017 Jul; 92():51-57. PubMed ID: 28624020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.
    Stanwell P; Gluch L; Clark D; Tomanek B; Baker L; Giuffrè B; Lean C; Malycha P; Mountford C
    Eur Radiol; 2005 May; 15(5):1037-43. PubMed ID: 15351906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
    Faeghi F; Baniasadipour B; Jalalshokouhi J
    Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.
    Başara I; Örgüç Ş; Coşkun T
    Diagn Interv Radiol; 2013; 19(3):221-6. PubMed ID: 23271501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.
    Bathen TF; Heldahl MG; Sitter B; Vettukattil R; Bofin A; Lundgren S; Gribbestad IS
    MAGMA; 2011 Dec; 24(6):347-57. PubMed ID: 21909791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton MR Spectroscopy in Assessing the Biochemical Milieu of Human Testes.
    Tsili AC; Astrakas L; Sofikitis N; Argyropoulou MI
    J Magn Reson Imaging; 2022 Feb; 55(2):404-413. PubMed ID: 33128500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
    Huang BY; Kwock L; Castillo M; Smith JK
    Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?
    Schmuecking M; Boltze C; Geyer H; Salz H; Schilling B; Wendt TG; Kloetzer KH; Marx C
    Int J Radiat Biol; 2009 Sep; 85(9):814-24. PubMed ID: 19701842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study.
    Baio G; Rescinito G; Rosa F; Pace D; Boccardo S; Basso L; Salvi S; Calabrese M; Truini M; Neumaier CE
    Mol Imaging Biol; 2015 Aug; 17(4):548-56. PubMed ID: 25613673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.
    Taylor JS; Langston JW; Reddick WE; Kingsley PB; Ogg RJ; Pui MH; Kun LE; Jenkins JJ; Chen G; Ochs JJ; Sanford RA; Heideman RL
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1251-61. PubMed ID: 8985051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton magnetic resonance spectroscopy in pituitary macroadenomas: preliminary results.
    Stadlbauer A; Buchfelder M; Nimsky C; Saeger W; Salomonowitz E; Pinker K; Richter G; Akutsu H; Ganslandt O
    J Neurosurg; 2008 Aug; 109(2):306-12. PubMed ID: 18671644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton MR spectroscopy of the breast.
    Tozaki M
    Breast Cancer; 2008; 15(3):218-23. PubMed ID: 18443899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the response of taurine protons to PRESS at 9.4 T for Resolving choline and Determining taurine T2.
    Fisher ME; Dobberthien BJ; Tessier AG; Yahya A
    NMR Biomed; 2016 Oct; 29(10):1427-35. PubMed ID: 27496562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
    Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
    AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of rectal cancer and response to concurrent chemoradiotherapy by proton magnetic resonance spectroscopy.
    Kim MJ; Lee SJ; Lee JH; Kim SH; Chun HK; Kim SH; Lim HK; Yun SH
    Magn Reson Imaging; 2012 Jul; 30(6):848-53. PubMed ID: 22503087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
    Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
    Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
    Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.